Facetten
Zugriff
Einrichtung
Medientyp
- Text 19
Karte
Erscheinungsjahr
Autor/in
- Häberle, Lothar
- Hadji, Peyman 11
- Hartkopf, Andreas D 11
- Tesch, Hans 11
- Fasching, Peter A 8
- alle zeigen
Sprache
- Englisch 19
19 Einträge gefunden
-
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT
- Engler, Tobias
- Fasching, Peter A
- Lüftner, Diana
- Hartkopf, Andreas D
- Müller, Volkmar
- Kolberg, Hans-Christian
- Hadji, Peyman
-
MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients
- Huebner, Hanna
- Häberle, Lothar
- Müller, Volkmar
- Schrader, Iris
- Lorenz, Ralf
- Forstbauer, Helmut
- Fink, Visnja
-
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry
- Müller, Volkmar
- Hein, Alexander
- Hartkopf, Andreas D
- Fasching, Peter A
- Kolberg, Hans-Christian
- Hadji, Peyman
- Tesch, Hans
-
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer - Association With Patient and Disease Characteristics and Effect on Prognosis
- Fasching, Peter A
- Yadav, Siddhartha
- Hu, Chunling
- Wunderle, Marius
- Häberle, Lothar
- Hart, Steven N
- Rübner, Matthias
-
-
Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
- Laakmann, Elena
- Emons, Julius
- Taran, Florin-Andrei
- Janni, Wolfgang
- Uhrig, Sabrina
- Overkamp, Friedrich
- Kolberg, Hans-Christian
-
-
-
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
- Michel, Laura L
- Hartkopf, Andreas D
- Fasching, Peter A
- Kolberg, Hans-Christian
- Hadji, Peyman
- Tesch, Hans
- Häberle, Lothar
-
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis
- Fasching, Peter A
- Hartkopf, Andreas D
- Gass, Paul
- Häberle, Lothar
- Akpolat-Basci, Leyla
- Hein, Alexander
- Volz, Bernhard
-
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians
- Gass, Paul
- Untch, Michael
- Müller, Volkmar
- Möbus, Volker
- Thomssen, Christoph
- Häberle, Lothar
- Erber, Ramona
-
Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry
- Müller, Volkmar
- Nabieva, Naiba
- Häberle, Lothar
- Taran, Florin-Andrei
- Hartkopf, Andreas D
- Volz, Bernhard
- Overkamp, Friedrich
-
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
- Lux, Michael P
- Nabieva, Naiba
- Hartkopf, Andreas D
- Huober, Jens
- Volz, Bernhard
- Taran, Florin-Andrei
- Overkamp, Friedrich
-
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry
- Hartkopf, Andreas D
- Huober, Jens
- Volz, Bernhard
- Nabieva, Naiba
- Taran, Florin-Andrei
- Schwitulla, Judith
- Overkamp, Friedrich
-
Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial
- Jueckstock, Julia
- Rack, Brigitte
- Friedl, Thomas W P
- Scholz, Christoph
- Steidl, Julia
- Trapp, Elisabeth
- Tesch, Hans
-
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study
- Hein, Alexander
- Lambrechts, Diether
- von Minckwitz, Gunter
- Häberle, Lothar
- Eidtmann, Holger
- Tesch, Hans
- Untch, Michael
-
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
- Nickels, Stefan
- Truong, Thérèse
- Hein, Rebecca
- Stevens, Kristen
- Buck, Katharina
- Behrens, Sabine
- Eilber, Ursula